NICE now recommends SGLT2 inhibitors as first-line therapy for people with established or high risk of cardiovascular disease, heart failure, or chronic kidney disease
These results suggest that Tirzepatide is a strong new option for treating metabolic diseases, especially for people who need help losing weight
Jensen SB, Sauerberg P, Nielsen FS, Pedersen BL, Skibsted E
Keeping weight in a healthy zone is very important for health reasons
Theres a lot of confusing information out there, and when youre also navigating gut issues, new food allergies, or autoimmune flare-ups , it can feel overwhelming, isolating, and honestly a little discouraging